Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy (Q43769949)

26 November 2017

Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy (English)

1 reference

26 November 2017

Coby Carlson

1

1 reference

26 November 2017

Chad Koonce

2

1 reference

26 November 2017

Natsuyo Aoyama

3

1 reference

26 November 2017

Shannon Einhorn

4

1 reference

26 November 2017

Steve Fiene

5

1 reference

26 November 2017

Arne Thompson

6

1 reference

26 November 2017

Brad Swanson

7

1 reference

26 November 2017

Blake Anson

8

1 reference

26 November 2017

Steven Kattman

9

1 reference

26 November 2017

26 September 2013

1 reference

Journal of Biomolecular Screening

26 November 2017

1 reference

26 November 2017

18

1 reference

26 November 2017

10

1 reference

26 November 2017

1203-1211

1 reference

Cardiac hypertrophy: the good, the bad, and the ugly

26 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Induction of pluripotent stem cells from fibroblast cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Induced pluripotent stem cells: a new approach for physiological research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Stem cells and their derivatives: a renaissance in cardiovascular translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Development of high content imaging methods for cell death detection in human pluripotent stem cell-derived cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Molecular regulation of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Transcriptional regulation of the fetal cardiac gene program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Return to the fetal gene program: a suggested metabolic link to gene expression in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

p90 ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to G(q)-protein-coupled receptor stimuli, endothelin-1 and α(1)-adrenergic receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Unrestrained p38 MAPK activation in Dusp1/4 double-null mice induces cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Natriuretic peptide testing in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

The why and how of phenotypic small-molecule screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

High content screening: seeing is believing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087057113500812

21 January 2018

Identifiers

DOI

10.1177/1087057113500812

1 reference

26 November 2017

1 reference